Article Text

Download PDFPDF
Use of paracetamol and ibuprofen in children in a tertiary care hospital: are we becoming complacent?
  1. Kate McCloskey1,
  2. Noel Cranswick1,2,
  3. Tom Connell1,3
  1. 1Department of General Medicine, Royal Children's Hospital, Parkville, Victoria, Australia
  2. 2Department of Clinical Pharmacology, The University of Melbourne, Melbourne, Victoria, Australia
  3. 3Department of Infectious Diseases, Royal Children's Hospital, Melbourne, Victoria, Australia
  1. Correspondence to Dr Kate McCloskey, Department of General Medicine, Royal Children's Hospital, Melbourne, Flemington Road, Parkville, Victoria 3052, Australia; katemccloskey{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Given the concerns regarding the routine administration of antipyretics (paracetamol and ibuprofen) in hospitalised children with fever, we recently audited antipyretic prescribing practices at the Royal Children's Hospital Melbourne, Australia (RCH). In this regard, we read with interest the recent editorial by McIntyre on the use of antipyretics in children with fever1 that shares our concerns.

As highlighted by McIntyre, there is no evidence that reducing fever in a sick child confers any benefit in reducing mortality. On the contrary, current evidence suggests that reducing fever through the use of antipyretics may in fact adversely affect the outcome following infection.1 In addition, …

View Full Text


  • Conflict of interest None.

  • Provenance and peer review Not commissioned; externally peer reviewed.